Paxil Antitrust Suit Bounces Back To State Court

Law360, New York (February 4, 2008, 12:00 AM EST) -- A federal judge on Thursday sent an antitrust lawsuit against GlaxoSmithKline Plc, maker of the popular antidepressent Paxil, back to state court, allowing plaintiffs to proceed with claims they first brought more than two years ago.

A group of health care plans led by Blue Cross Blue Shield of Minnesota sued Glaxo in the U.S. District Court for the District of Minnesota in 2005, alleging that the company had used groundless patent lawsuits and false patent listings to keep generic competition out of the market for...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.